Clinical Trials Logo

Fatigue clinical trials

View clinical trials related to Fatigue.

Filter by:

NCT ID: NCT04995614 Completed - Bone Metastases Clinical Trials

Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223

Start date: April 1, 2017
Phase:
Study type: Observational

The aim of the current prospective multicenter study is to evaluate cancer-specific and bone metastases related HR-QoL, psychological distress and fatigue in mCRPC patients before, during and after treatment with radium-223 in daily practice. Furthermore, the investigators aim to determine patient groups with identical health-related quality of life patterns over time, in order to identify variables related to health-related quality of life deterioration during the course of treatment, as patients with health-related quality of life deterioration may need specific attention to preserve health-related quality of life.

NCT ID: NCT04994600 Completed - Alarm Fatigue Clinical Trials

Design and Validation of a German Language Questionnaire for Measuring Alarm Fatigue in Intensive Care Units

alarmZen1
Start date: March 19, 2021
Phase:
Study type: Observational

False-positive and non-actionable alarms can lead to staff desensitization ("alarm fatigue") and thus patient endangerment. With this study the investigators create a basic tool to survey alarm fatigue of intensive care staff: the first German language alarm fatigue questionnaire.

NCT ID: NCT04983342 Completed - Fatigue Clinical Trials

Apollo Device for Metastatic Breast Cancer (MBC)

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This is a single-arm, open label pilot intervention study with outcomes measured by electronic survey and chart review evaluating a wearable device called Apollo, which is similar to a FitBit but emits vibrations. Our primary objective is to assess whether or not Apollo can help with symptoms of fatigue and pain in patients with Metastatic Breast Cancer (MBC).

NCT ID: NCT04980573 Completed - Covid19 Clinical Trials

Essential Oils and Post COVID-19 Fatigue

Start date: August 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of plant based aromas on energy levels among otherwise healthy female survivors of COVID-19.

NCT ID: NCT04975802 Completed - Cognition Clinical Trials

Effect of Coffeeberry on Mood and Cognitive Performance

Start date: July 5, 2021
Phase: N/A
Study type: Interventional

The primary aim of this randomised, double-blind, placebo-controlled, cross-over study is to assess the short-term cognitive effects of two beverages containing 100 and 300 mg coffeeberry extract (obtained from the fruit of the coffee plant (Coffea arabica) compared to a placebo beverage. The trial will utilise the COMPASS cognitive assessment system and cognitive demand battery (CDB) and mood visual analogue scales (VAS) with assessments taking place at baseline, 60- and 120-minutes post treatment, on four separate testing days separated by 7 days. A treatment containing 75 mg caffeine will be used as a positive control to document participants' responsiveness to an established psychostimulant.

NCT ID: NCT04974606 Completed - Mood Clinical Trials

Effect of Coffeeberry on Mood, Motivation and Cognitive Performance

Start date: June 28, 2016
Phase: N/A
Study type: Interventional

The primary purpose is to test the short-term effects of the acute consumption of two novel beverages made from coffeeberries, the fruit of the coffee plant (Coffea arabica) benchmarked against caffeine on several aspects of cognitive performance. Preliminary studies suggest that flavanols and chlorogenic acids can enhance cognitive performance. It is unknown if drinks formulated with flavanols and chlorogenic acids (without high sugar or caffeine) improve cognition or mood to a similar extent as caffeine. Coffeeberry beverage comparisons will be made to a flavored positive control beverage containing caffeine and a flavored placebo beverage.

NCT ID: NCT04961476 Completed - Covid19 Clinical Trials

Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19

Start date: January 8, 2021
Phase:
Study type: Observational [Patient Registry]

Coronavirus disease 2019 (COVID-19) is a serious respiratory disease that results from infection with a newly discovered coronavirus (SARS-COV-2). Unfortunately, COVID-19 is not only a short-term infection but that patients (pts) recovering from SARS-COV2 infection complain of persisting symptoms including: fatigue, diffuse myalgia and weakness, which may lead to chronic fatigue syndrome. There is currently no evidence that nutritional supplements and/or physical exercise can assist in the recovery of pts with chronic fatigue syndrome. 1-Methylnicotinamide (1-MNA) is an endogenic substance that is produced in the liver when nicotinic acid is metabolized. 1-MNA demonstrates anti-inflammatory and anti-thrombotic properties. Therefore, we investigated whether 1-MNA supplements could improve exercise tolerance and decrease fatigue among patients recovering from SARS-COV-2.

NCT ID: NCT04960865 Completed - Fatigue Clinical Trials

Kinesio Taping and Calf Muscle Fatigue

Start date: September 6, 2021
Phase: N/A
Study type: Interventional

Muscle fatigue results in decreased ability in muscles to generate force. Kinesio Tape may reverse the adverse effects of fatigue. Thus this study will examine the acute effects of Kinesio tape on muscle fatigue.

NCT ID: NCT04959214 Completed - Fatigue Clinical Trials

The Effect Of Progressıve Relaxatıon Exercıses

Start date: September 9, 2020
Phase: N/A
Study type: Interventional

This study was conducted to evaluate the effect of progressive relaxation exercises applied to nurses working in the intensive care unit three times a week for 1 month on sleep quality and severity of fatigue. The research is a pretest-posttest randomized controlled study with an intervention control group.

NCT ID: NCT04954430 Completed - Mental Fatigue Clinical Trials

The Reliability Assessment of Emergency Paramedics' Fatigue Using Automated Pupillometry

Start date: November 14, 2020
Phase:
Study type: Observational

Due to the limitations of current approaches to assess emergency paramedics' fatigue, a portable, quick, easy, and objective technique is required to be developed. The aim of the study was to investigate the reliability of automated pupillometry to assess mental fatigue based on a driver simulator.